News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
441,386 Results
Type
Article (31008)
Company Profile (118)
Press Release (410248)
Multimedia
Podcasts (77)
Webinars (15)
Section
Business (110027)
Career Advice (984)
Deals (19758)
Drug Delivery (103)
Drug Development (42343)
Employer Resources (109)
FDA (11803)
Job Trends (10864)
News (191560)
Policy (23706)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2185)
Academic (2)
Accelerated approval (24)
Adcomms (21)
Allergies (98)
Alliances (30495)
ALS (101)
Alzheimer's disease (1202)
Antibody-drug conjugate (ADC) (169)
Approvals (12044)
Artificial intelligence (401)
Autoimmune disease (89)
Automation (23)
Bankruptcy (196)
Best Places to Work (9401)
BIOSECURE Act (8)
Biosimilars (166)
Biotechnology (61)
Bladder cancer (115)
Brain cancer (39)
Breast cancer (406)
Cancer (2892)
Cardiovascular disease (319)
Career advice (884)
Career pathing (26)
CAR-T (132)
CDC (53)
Cell therapy (405)
Cervical cancer (26)
Clinical research (37031)
Collaboration (1143)
Company closure (3)
Compensation (178)
Complete response letters (44)
COVID-19 (2404)
CRISPR (58)
C-suite (527)
Cystic fibrosis (95)
Data (3987)
Decentralized trials (2)
Denatured (22)
Depression (115)
Diabetes (369)
Diagnostics (5620)
Digital health (45)
Diversity (10)
Diversity, equity & inclusion (27)
Drug discovery (159)
Drug pricing (187)
Drug shortages (23)
Duchenne muscular dystrophy (151)
Earnings (40181)
Editorial (47)
Employer branding (9)
Employer resources (98)
Events (78937)
Executive appointments (692)
FDA (14154)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (4)
Frontotemporal dementia (17)
Funding (1068)
Gene editing (114)
Generative AI (38)
Gene therapy (330)
GLP-1 (668)
Government (4573)
Grass and pollen (6)
Guidances (326)
Healthcare (15633)
HIV (54)
Huntington's disease (25)
IgA nephropathy (52)
Immunology and inflammation (138)
Immuno-oncology (38)
Indications (76)
Infectious disease (2654)
Inflammatory bowel disease (130)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (126)
Interviews (164)
IPO (8490)
IRA (47)
Job creations (1844)
Job search strategy (738)
JPM (61)
Kidney cancer (5)
Labor market (50)
Layoffs (363)
Leadership (27)
Legal (5102)
Liver cancer (58)
Longevity (12)
Lung cancer (369)
Lymphoma (240)
Machine learning (29)
Management (44)
Manufacturing (452)
MASH (116)
Medical device (10047)
Medtech (10093)
Mergers & acquisitions (12005)
Metabolic disorders (925)
Multiple sclerosis (122)
NASH (13)
Neurodegenerative disease (208)
Neuropsychiatric disorders (70)
Neuroscience (2070)
Neurotech (1)
NextGen: Class of 2026 (5161)
Non-profit (4029)
Now hiring (16)
Obesity (433)
Opinion (209)
Ovarian cancer (86)
Pain (124)
Pancreatic cancer (99)
Parkinson's disease (180)
Partnered (25)
Patents (263)
Patient recruitment (299)
Peanut (35)
People (35488)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (11521)
Phase 2 (14681)
Phase 3 (13392)
Pipeline (3639)
Policy (262)
Postmarket research (1651)
Preclinical (3701)
Press Release (47)
Prostate cancer (166)
Psychedelics (45)
Radiopharmaceuticals (177)
Rare diseases (594)
Real estate (3149)
Recruiting (47)
Regulatory (17434)
Reports (26)
Research institute (2017)
Resumes & cover letters (97)
Rett syndrome (22)
RNA editing (7)
RSV (71)
Schizophrenia (122)
Series A (165)
Series B (134)
Service/supplier (4)
Sickle cell disease (75)
Special edition (12)
Spinal muscular atrophy (107)
Sponsored (31)
Startups (2209)
Stomach cancer (9)
Supply chain (77)
Tariffs (52)
The Weekly (54)
Vaccines (890)
Venture capital (71)
Weight loss (274)
Women's health (83)
Worklife (13)
Date
Last 7 days (382)
Last 30 days (1459)
Last 365 days (20181)
2026 (2014)
2025 (20601)
2024 (23441)
2023 (26115)
2022 (35881)
2021 (39270)
2020 (39691)
2019 (34899)
2018 (26241)
2017 (19276)
2016 (20100)
2015 (22847)
2014 (17189)
2013 (13717)
2012 (14573)
2011 (14961)
2010 (12954)
Location
Africa (595)
Alabama (66)
Alaska (6)
Arizona (191)
Arkansas (11)
Asia (23897)
Australia (4205)
California (6746)
Canada (2267)
China (666)
Colorado (339)
Connecticut (349)
Delaware (206)
Europe (55390)
Florida (1051)
Georgia (265)
Hawaii (2)
Idaho (40)
Illinois (622)
India (55)
Indiana (462)
Iowa (13)
Japan (310)
Kansas (90)
Kentucky (27)
Louisiana (25)
Maine (79)
Maryland (995)
Massachusetts (4969)
Michigan (233)
Minnesota (427)
Mississippi (3)
Missouri (121)
Montana (19)
Nebraska (22)
Nevada (94)
New Hampshire (61)
New Jersey (2262)
New Mexico (13)
New York (2046)
North Carolina (1016)
North Dakota (5)
Northern California (3329)
Ohio (229)
Oklahoma (14)
Oregon (29)
Pennsylvania (1486)
Puerto Rico (12)
Rhode Island (30)
South America (761)
South Carolina (36)
South Dakota (1)
Southern California (2566)
Tennessee (145)
Texas (979)
United States (26113)
Utah (274)
Virginia (155)
Washington D.C. (56)
Washington State (639)
West Virginia (3)
Wisconsin (94)
Wyoming (2)
441,386 Results for "health decisions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Regulatory
6 FDA Decisions To Watch For in Q4
From more than 30 target action dates in the last three months of the year,
BioSpace
has narrowed the list to six regulatory decisions that could have far-reaching implications for biopharma and patients.
September 29, 2025
·
9 min read
·
Tristan Manalac
FDA
6 FDA Decisions To Watch in Q1 2026
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after being delayed from the fourth quarter last year.
January 12, 2026
·
8 min read
·
Tristan Manalac
Press Releases
SiPhox Health Introduces a Smarter Way of Health Tracking From Home
February 3, 2026
·
1 min read
Press Releases
Florida Health Department Retreats on HIV/AIDS Drug Cuts
February 4, 2026
·
2 min read
Press Releases
Alira Health Opens the Registration for the Third Edition of the Global Payer Forum
January 29, 2026
·
3 min read
Press Releases
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
February 2, 2026
·
7 min read
Press Releases
Truvian Health Rapidly Expands TruVerus™ Menu with FDA Clearances for Cardiovascular, Liver, and Core Metabolic Health Tests
January 12, 2026
·
4 min read
Press Releases
Insightec Secures Health Canada Approval for Exablate® Prime System
February 5, 2026
·
3 min read
1 of 44,139
Next
